Eyegate Pharmaceuticals (Warrant)

YTD

ALL

Why Robinhood?

You can watch EYEGW and buy or sell other stocks, ETFs, and their options commission-free!

About EYEGW

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102.

CEO

Brian Matthew Strem, PhD

CEOBrian Matthew Strem, PhD

Employees

—

Employees—

Headquarters

Encinitas, California

HeadquartersEncinitas, California

Founded

1998

Founded1998

Employees

—

Employees—

EYEGW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—